Despite pandemic conditions that made normal signature-gathering almost impossible, activists in Washington, D.C., say they have enough signatures for a November ballot initiative that would decriminalize natural psychedelics such as certain mushrooms.
By Ashraf Khalil, Associated Press
A total of 2,367 police officers have been fired, 4,100 suspended while the rest were reprimanded, demoted, had their salaries forfeited or deprived of certain privileges.
By Jim Gomez, Associated Press
Federal authorities said the seizure, which they value at $1.1 billion, is the largest cocaine haul in the history of U.S. Customs.
By Associated Press
Heaping bags of fentanyl and plastic tubs of crystal meth, heroin and cocaine offer no sign that the cartel has been weakened, lost sway over its traditional territory in northwestern Mexico or seen its international reach curtailed.
By Maria Verza, Mark Stevenson, Associated Press
By Helen Branswell, STAT
The struggle against HIV may be undergoing a sea change.
The PBS NewsHour Weekend reporting team is gathering stories about the high cost of prescription drugs and patients’ experiences at the pharmacy.
By Kay Colby, ideastream
The pathway to deadly heart infections for people addicted to opioids often begins with a dirty needle or polluted drug. Special correspondent Kay Colby of Ideastream reports on a little-known problem with big consequences for patients and society as a…
By PBS NewsHour
Amid several lawsuits that accuse manufacturing giant Purdue Pharma of contributing to the country’s opioid epidemic, the company announced Saturday it will cut sales staff by more than half and stop marketing opioids to doctors. Reporter Lev Facher, who wrote…
By Matthew Perrone, Ricardo Alonso-Zaldivar, Associated Press
As a candidate, Trump advocated Medicare negotiations and he called for allowing consumers to import lower-priced medicines from abroad. But the White House strategy paper veers away from such dramatic steps.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.